AskGene Presents Encouraging Clinical Results on ASKB589 at ASCO-GI 2023
Camarillo, California, January 24, 2023 – AskGene Pharma Inc. presented encouraging clinical results for ASKB589, an anti-CLDN18.2 antibody, at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium (ASCO-GI 2023) in San Francisco on January 19-21, 2023. The results were from clinical trial NCT04632108, a Phase I/II, two-part, dose escalation and expansion study to evaluate […]